glp-1 obesity drug market news today october 2025 Obesity GLP-1 Ground News | Federal regulators

Combined anabolic and micronutrient vulnerabilities in these populations may influence musculoskeletal resilience

Birth of the incretin concept The same year Lim and Kosaka published their hypothesis, the Belgian physiologist La Barre attempted to purify secretin with Eugene Still, a colleague at the University of Chicago

Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat

The number of acute pancreatitis adverse events steadily increased from 16 in 2005 to 459 in 2023 (Q1-Q3), peaking in 2011, reflecting the growing clinical utilization of GLP-1 RAs (Figure 1)

Are there oral options for GLP-1 agonists

Nonalcoholic fatty liver disease and type 2 diabetes: Pathophysiological mechanisms shared between the two faces of the same coin